
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddhant Kabra
Filed with BSE ·

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddhant Kabra
6ix hasn’t read this filing yet.
Eiko Lifesciences Limited on 6ix
Follow Eiko Lifesciences into a list and get an email when it puts out news.
Follow Eiko Lifesciences